{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:23:36Z","timestamp":1794936216807,"version":"4.9.1"},"reference-count":105,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T00:00:00Z","timestamp":1297123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2,8]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Familial haemophagocytic lymphohistiocytosis (FHL) is a rare autosomal recessive disorder of immune dysregulation associated with uncontrolled T cell and macrophage activation and hypercytokinaemia. The incidence of FHL is 0\u00b712\/100\u00b7000 children born per year, with a male to female ratio of 1:1. The disease is classified into six different types based on genetic linkage analysis and chromosomal localization; five specific genetic defects have been identified, which account for approximately 90% of all patients. Type 1 is due to an as yet unidentified gene defect located on chromosome nine. Type 2 is caused by mutations in the perforin (PRF1) gene, type 3 by mutations in the Munc-13\u20134 (UNC13D) gene, type 4 by mutations in the syntaxin 11 (STX11) gene and the recently described type 5 due to mutations in the gene encoding syntaxin binding protein 2 (STXBP-2). The incidence of the five types varies in different ethnic groups. The most common presenting features are pyrexia of unknown origin, pronounced hepatosplenomegaly and cytopenias. Neurological features tend to present later and are associated with poor prognosis. Absent or decreased lymphocyte cytotoxicity is the cellular hallmark of FHL. Biochemical features such as hyperferritinaemia, hypertriglyceridaemia and hypofibrinogenaemia are usually present, along with high levels of soluble interleukin 2 receptor in the blood and cerebrospinal fluid. Bone marrow aspirate may demonstrate the characteristic haemophagocytes, but initially is non-diagnostic in two-thirds of patients. Established international clinical, haematological and biochemical criteria now facilitate accurate clinical diagnosis. The disease is fatal unless a haematopoietic stem cell transplant (HSCT) is performed. The introduction of HSCT has dramatically improved the prognosis of the disease. However, the mortality of the disease is still significantly high and a number of challenges remain to be addressed. Active disease at the time of the transplant is the major significant poor prognostic factor. Delayed diagnosis, after irreversible organ damage has occurred, especially neurological damage, disease reoccurrence and pre-transplant mortality, remain a concern.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2010.04302.x","type":"journal-article","created":{"date-parts":[[2011,2,9]],"date-time":"2011-02-09T06:39:55Z","timestamp":1297233595000},"page":"271-283","source":"Crossref","is-referenced-by-count":149,"title":["Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management"],"prefix":"10.1093","volume":"163","author":[{"given":"C","family":"Gholam","sequence":"first","affiliation":[{"name":"Department of Dermatology, Great Ormond Street Hospital NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Grigoriadou","sequence":"additional","affiliation":[{"name":"Department of Immunology, Barts and The London NHS Trust, Royal London Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K C","family":"Gilmour","sequence":"additional","affiliation":[{"name":"Centre for Immunodeficiency, Molecular Immunology Unit, UCL Institute of Child Health, London, UK"},{"name":"Department of Clinical Immunology, Great Ormond Street Hospital NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H B","family":"Gaspar","sequence":"additional","affiliation":[{"name":"Centre for Immunodeficiency, Molecular Immunology Unit, UCL Institute of Child Health, London, UK"},{"name":"Department of Clinical Immunology, Great Ormond Street Hospital NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,2,8]]},"reference":[{"key":"2021122708482622100_b1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1182\/asheducation-2005.1.82","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","author":"Janka","year":"2005","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"2021122708482622100_b2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/adc.27.136.519","article-title":"Familial haemophagocytic reticulosis","volume":"27","author":"Farquhar","year":"1952","journal-title":"Arch Dis Child"},{"key":"2021122708482622100_b3","first-page":"197","article-title":"Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society","volume":"10","author":"Arico","year":"1996","journal-title":"Leukemia"},{"key":"2021122708482622100_b4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1651-2227.1991.tb11878.x","article-title":"Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis","volume":"80","author":"Henter","year":"1991","journal-title":"Acta Paediatr Scand"},{"key":"2021122708482622100_b5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/(SICI)1096-911X(199805)30:5<276::AID-MPO3>3.0.CO;2-C","article-title":"Clinical and epidemiologic studies of familial hemophagocytic lymphohistiocytosis in Japan. Japan LCH Study Group","volume":"30","author":"Ishii","year":"1998","journal-title":"Med Pediatr Oncol"},{"key":"2021122708482622100_b6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/08880010390203891","article-title":"Primary hemophagocytic lymphohistiocytosis in Turkish children","volume":"20","author":"Gurgey","year":"2003","journal-title":"Pediatr Hematol Oncol"},{"key":"2021122708482622100_b7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"key":"2021122708482622100_b8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.0105-2896.2005.00224.x","article-title":"Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis","volume":"203","author":"Menasche","year":"2005","journal-title":"Immunol Rev"},{"key":"2021122708482622100_b9","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.290.5495.1354","article-title":"Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma","volume":"290","author":"Badovinac","year":"2000","journal-title":"Science (NY)"},{"key":"2021122708482622100_b10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1074-7613(03)00079-7","article-title":"Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice","volume":"18","author":"Badovinac","year":"2003","journal-title":"Immunity"},{"key":"2021122708482622100_b11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1084\/jem.20062447","article-title":"Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis","volume":"204","author":"Crozat","year":"2007","journal-title":"J Exp Med"},{"key":"2021122708482622100_b12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00431-006-0258-1","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"166","author":"Janka","year":"2007","journal-title":"Eur J Pediatr"},{"key":"2021122708482622100_b13","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1182\/blood.V89.11.4100","article-title":"Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis","volume":"89","author":"Osugi","year":"1997","journal-title":"Blood"},{"key":"2021122708482622100_b14","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/blood-2001-12-0260","article-title":"Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis","volume":"100","author":"Schneider","year":"2002","journal-title":"Blood"},{"key":"2021122708482622100_b15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1365-2141.1999.01504.x","article-title":"Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity","volume":"106","author":"Takada","year":"1999","journal-title":"Br J Haematol"},{"key":"2021122708482622100_b16","first-page":"1583","article-title":"MIP-1alpha expression in tissues from patients with hemophagocytic syndrome","volume":"79","author":"Teruya-Feldstein","year":"1999","journal-title":"Lab Invest"},{"key":"2021122708482622100_b17","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.V78.11.2918.2918","article-title":"Hypercytokinemia in familial hemophagocytic lymphohistiocytosis","volume":"78","author":"Henter","year":"1991","journal-title":"Blood"},{"key":"2021122708482622100_b18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1651-2227.1991.tb11928.x","article-title":"Lipoprotein alterations and plasma lipoprotein lipase reduction in familial hemophagocytic lymphohistiocytosis","volume":"80","author":"Henter","year":"1991","journal-title":"Acta Paediatr Scand"},{"key":"2021122708482622100_b19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.cellbio.23.090506.123521","article-title":"Secretory mechanisms in cell-mediated cytotoxicity","volume":"23","author":"Stinchcombe","year":"2007","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2021122708482622100_b20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1086\/302187","article-title":"Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping","volume":"64","author":"Ohadi","year":"1999","journal-title":"Am J Hum Genet"},{"key":"2021122708482622100_b21","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science (NY)"},{"key":"2021122708482622100_b22","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nri1983","article-title":"Perforin-mediated target-cell death and immune homeostasis","volume":"6","author":"Voskoboinik","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"2021122708482622100_b23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1172\/JCI26217","article-title":"Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis","volume":"116","author":"Risma","year":"2006","journal-title":"J Clin Invest"},{"key":"2021122708482622100_b24","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1182\/blood-2003-10-3551","article-title":"Atypical features of familial hemophagocytic lymphohistiocytosis","volume":"103","author":"Busiello","year":"2004","journal-title":"Blood"},{"key":"2021122708482622100_b25","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2002-04-1030","article-title":"Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations","volume":"100","author":"Clementi","year":"2002","journal-title":"Blood"},{"key":"2021122708482622100_b26","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2004-04-1477","article-title":"A proportion of patients with lymphoma may harbor mutations of the perforin gene","volume":"105","author":"Clementi","year":"2005","journal-title":"Blood"},{"key":"2021122708482622100_b27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2141.2002.03534.x","article-title":"Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis","volume":"117","author":"Feldmann","year":"2002","journal-title":"Br J Haematol"},{"key":"2021122708482622100_b28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1086\/318796","article-title":"Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis","volume":"68","author":"Goransdotter Ericson","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2021122708482622100_b29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood.V99.1.61","article-title":"Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members","volume":"99","author":"Kogawa","year":"2002","journal-title":"Blood"},{"key":"2021122708482622100_b30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpeds.2006.03.003","article-title":"Patients of African ancestry with hemophagocytic lymphohistiocytosis share a common haplotype of PRF1 with a 50delT mutation","volume":"149","author":"Lee","year":"2006","journal-title":"J Pediatr"},{"key":"2021122708482622100_b31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jmg.2003.011528","article-title":"Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis","volume":"41","author":"Molleran Lee","year":"2004","journal-title":"J Med Genet"},{"key":"2021122708482622100_b32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-2141.2002.03266.x","article-title":"Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan","volume":"116","author":"Suga","year":"2002","journal-title":"Br J Haematol"},{"key":"2021122708482622100_b33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ajh.20878","article-title":"Late-onset cases of familial hemophagocytic lymphohistiocytosis with missense perforin gene mutations","volume":"82","author":"Ueda","year":"2007","journal-title":"Am J Hematol"},{"key":"2021122708482622100_b34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2141.2003.04298.x","article-title":"Characteristic perforin gene mutations of haemophagocytic lymphohistiocytosis patients in Japan","volume":"121","author":"Ueda","year":"2003","journal-title":"Br J Haematol"},{"key":"2021122708482622100_b35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/humu.20274","article-title":"Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A","volume":"27","author":"Zur Stadt","year":"2006","journal-title":"Hum Mutat"},{"key":"2021122708482622100_b36","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1182\/blood-2004-09-3713","article-title":"A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin","volume":"106","author":"Trambas","year":"2005","journal-title":"Blood"},{"key":"2021122708482622100_b37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"key":"2021122708482622100_b38","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/jmg.2006.041863","article-title":"Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis","volume":"43","author":"Santoro","year":"2006","journal-title":"J Med Genet"},{"key":"2021122708482622100_b39","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1182\/blood-2004-08-3296","article-title":"Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte\/natural killer cell functions","volume":"105","author":"Ishii","year":"2005","journal-title":"Blood"},{"key":"2021122708482622100_b40","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/hmg\/ddi076","article-title":"Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11","volume":"14","author":"zur Stadt","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2021122708482622100_b41","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.4049\/jimmunol.179.6.3397","article-title":"Cutting edge: syntaxin 11 regulates lymphocyte-mediated secretion and cytotoxicity","volume":"179","author":"Arneson","year":"2007","journal-title":"J Immunol"},{"key":"2021122708482622100_b42","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2007-02-074468","article-title":"Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients","volume":"110","author":"Bryceson","year":"2007","journal-title":"Blood"},{"key":"2021122708482622100_b43","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1136\/jmg.2005.035253","article-title":"Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignancies","volume":"43","author":"Rudd","year":"2006","journal-title":"J Med Genet"},{"key":"2021122708482622100_b44","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s10038-005-0293-1","article-title":"Mutations of syntaxin 11 and SNAP23 genes as causes of familial hemophagocytic lymphohistiocytosis were not found in Japanese people","volume":"50","author":"Yamamoto","year":"2005","journal-title":"J Hum Genet"},{"key":"2021122708482622100_b45","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1172\/JCI40732","article-title":"Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells","volume":"119","author":"Cote","year":"2009","journal-title":"J Clin Invest"},{"key":"2021122708482622100_b46","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","article-title":"Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11","volume":"85","author":"zur Stadt","year":"2009","journal-title":"Am J Hum Genet"},{"key":"2021122708482622100_b47","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.bbamcr.2008.05.023","article-title":"Involvement of Munc18 isoforms in the regulation of granule exocytosis in neutrophils","volume":"1783","author":"Brochetta","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"2021122708482622100_b48","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1242\/jcs.00216","article-title":"Evidence of a role for Munc18-2 and microtubules in mast cell granule exocytosis","volume":"116","author":"Martin-Verdeaux","year":"2003","journal-title":"J Cell Sci"},{"key":"2021122708482622100_b49","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/pbc.20511","article-title":"Correlation between phenotypic heterogeneity and gene mutational characteristics in familial hemophagocytic lymphohistiocytosis (FHL)","volume":"46","author":"Ueda","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"2021122708482622100_b50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2141.2008.07315.x","article-title":"Characterization of PRF1, STX11 and UNC13D genotype\u2013phenotype correlations in familial hemophagocytic lymphohistiocytosis","volume":"143","author":"Horne","year":"2008","journal-title":"Br J Haematol"},{"key":"2021122708482622100_b51","volume-title":"Hemophagocytic lymphohistiocytosis (HLH)\u2003\u2013\u2003symptoms, signs and diagnosis of a rapidly fatal childhood disease","author":"Henter"},{"key":"2021122708482622100_b52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0889-8588(05)70520-7","article-title":"Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis","volume":"12","author":"Henter","year":"1998","journal-title":"Hematol Oncol Clin North Am"},{"key":"2021122708482622100_b53","first-page":"499","article-title":"Familial hemophagocytic lymphohistiocytosis: how late can the onset be?","volume":"86","author":"Allen","year":"2001","journal-title":"Haematologica"},{"key":"2021122708482622100_b54","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/MPH.0b013e31802d3a96","article-title":"Prolonged course of familial hemophagocytic lymphohistiocytosis","volume":"28","author":"Steinberg","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021122708482622100_b55","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00443367","article-title":"Familial hemophagocytic lymphohistiocytosis","volume":"140","author":"Janka","year":"1983","journal-title":"Eur J Pediatr"},{"key":"2021122708482622100_b56","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1651-2227.1993.tb12699.x","article-title":"Familial hemophagocytic lymphohistiocytosis and viral infections","volume":"82","author":"Henter","year":"1993","journal-title":"Acta Paediatr"},{"key":"2021122708482622100_b57","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1203\/00006450-199810000-00001","article-title":"Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives","volume":"44","author":"Sullivan","year":"1998","journal-title":"Pediatr Res"},{"key":"2021122708482622100_b58","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/08880018909034294","article-title":"Familial hemophagocytic lymphohistiocytosis: clinical features","volume":"6","author":"Arico","year":"1989","journal-title":"Pediatr Hematol Oncol"},{"key":"2021122708482622100_b59","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood.V73.8.2128.2128","article-title":"Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes","volume":"73","author":"Komp","year":"1989","journal-title":"Blood"},{"key":"2021122708482622100_b60","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/pbc.21564","article-title":"The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis","volume":"51","author":"Gupta","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"2021122708482622100_b61","first-page":"29","article-title":"Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society","volume":"18","author":"Henter","year":"1991","journal-title":"Semin Oncol"},{"key":"2021122708482622100_b62","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/08880018909034290","article-title":"Familial hemophagocytic lymphohistiocytosis: diagnostic problems and differential diagnosis","volume":"6","author":"Janka","year":"1989","journal-title":"Pediatr Hematol Oncol"},{"key":"2021122708482622100_b63","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1651-2227.1991.tb11849.x","article-title":"Familial hemophagocytic lymphohistiocytosis. Clinical review based on the findings in seven children","volume":"80","author":"Henter","year":"1991","journal-title":"Acta Paediatr Scand"},{"key":"2021122708482622100_b64","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"2021122708482622100_b65","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1182\/blood-2004-09-3651","article-title":"Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members","volume":"105","author":"Tabata","year":"2005","journal-title":"Blood"},{"key":"2021122708482622100_b66","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J Immunol Methods"},{"key":"2021122708482622100_b67","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.leu.2403704","article-title":"CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets","volume":"19","author":"Penack","year":"2005","journal-title":"Leukemia"},{"key":"2021122708482622100_b68","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2006-04-015693","article-title":"Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease","volume":"108","author":"Marcenaro","year":"2006","journal-title":"Blood"},{"key":"2021122708482622100_b69","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/pd.231","article-title":"Prenatal diagnosis of perforin gene mutations in familial hemophagocytic lymphohistiocytosis (FHLH)","volume":"22","author":"zur Stadt","year":"2002","journal-title":"Prenat Diagn"},{"key":"2021122708482622100_b70","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/2424","article-title":"Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene","volume":"20","author":"Coffey","year":"1998","journal-title":"Nat Genet"},{"key":"2021122708482622100_b71","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/1097-0215(20001101)88:3<439::AID-IJC17>3.0.CO;2-#","article-title":"SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines","volume":"88","author":"Nagy","year":"2000","journal-title":"Int J Cancer"},{"key":"2021122708482622100_b72","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.immunol.25.022106.141651","article-title":"Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules","volume":"25","author":"Ma","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"2021122708482622100_b73","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1182\/blood-2004-08-3269","article-title":"SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells","volume":"105","author":"Dupre","year":"2005","journal-title":"Blood"},{"key":"2021122708482622100_b74","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"key":"2021122708482622100_b75","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.0105-2896.2005.00230.x","article-title":"Molecular and cellular pathogenesis of X-linked lymphoproliferative disease","volume":"203","author":"Nichols","year":"2005","journal-title":"Immunol Rev"},{"key":"2021122708482622100_b76","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1203\/00006450-199510000-00001","article-title":"X-linked lymphoproliferative disease: twenty-five years after the discovery","volume":"38","author":"Seemayer","year":"1995","journal-title":"Pediatr Res"},{"key":"2021122708482622100_b77","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood.V97.4.1131","article-title":"Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene","volume":"97","author":"Arico","year":"2001","journal-title":"Blood"},{"key":"2021122708482622100_b78","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng0797-289","article-title":"Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene","volume":"16","author":"Pastural","year":"1997","journal-title":"Nat Genet"},{"key":"2021122708482622100_b79","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/76024","article-title":"Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome","volume":"25","author":"Menasche","year":"2000","journal-title":"Nat Genet"},{"key":"2021122708482622100_b80","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1172\/JCI200318264","article-title":"Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1)","volume":"112","author":"Menasche","year":"2003","journal-title":"J Clin Invest"},{"key":"2021122708482622100_b81","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1083\/jcb.152.4.825","article-title":"Rab27a is required for regulated secretion in cytotoxic T lymphocytes","volume":"152","author":"Stinchcombe","year":"2001","journal-title":"J Cell Biol"},{"key":"2021122708482622100_b82","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1091\/mbc.e04-10-0923","article-title":"Munc13-4 is an effector of rab27a and controls secretion of lysosomes in hematopoietic cells","volume":"16","author":"Neeft","year":"2005","journal-title":"Mol Biol Cell"},{"key":"2021122708482622100_b83","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ng1196-307","article-title":"Identification and mutation analysis of the complete gene for Chediak\u2013Higashi syndrome","volume":"14","author":"Nagle","year":"1996","journal-title":"Nat Genet"},{"key":"2021122708482622100_b84","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.genom.9.081307.164303","article-title":"Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics","volume":"9","author":"Huizing","year":"2008","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2021122708482622100_b85","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0749.2005.00289.x","article-title":"Hermansky\u2013Pudlak syndrome: a disease of protein trafficking and organelle function","volume":"19","author":"Wei","year":"2006","journal-title":"Pigment Cell Res"},{"key":"2021122708482622100_b86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1182\/blood-2005-11-4413","article-title":"Lethal hemophagocytic lymphohistiocytosis in Hermansky\u2013Pudlak syndrome type II","volume":"108","author":"Enders","year":"2006","journal-title":"Blood"},{"key":"2021122708482622100_b87","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/(SICI)1096-8628(19991203)87:4<329::AID-AJMG9>3.0.CO;2-M","article-title":"Hemophagocytic lymphohistiocytosis in a patient with deletion of 22q11.2","volume":"87","author":"Arico","year":"1999","journal-title":"Am J Med Genet"},{"key":"2021122708482622100_b88","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1099\/jmm.0.47071-0","article-title":"Bacteria-associated haemophagocytic syndrome and septic pulmonary embolism caused by Burkholderia cepacia complex in a woman with chronic granulomatous disease","volume":"56","author":"Hisano","year":"2007","journal-title":"J Med Microbiol"},{"key":"2021122708482622100_b89","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/tropej\/fmm024","article-title":"Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis","volume":"53","author":"Tapisiz","year":"2007","journal-title":"J Trop Pediatr"},{"key":"2021122708482622100_b90","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1542\/peds.106.4.e58","article-title":"Hemophagocytic syndrome: a misleading complication of visceral leishmaniasis in children\u2003\u2013\u2003a series of 12 cases","volume":"106","author":"Gagnaire","year":"2000","journal-title":"Pediatrics"},{"key":"2021122708482622100_b91","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jinf.2008.02.013","article-title":"Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis\u2003\u2013\u2003case report and systematic review","volume":"56","author":"Rajagopala","year":"2008","journal-title":"J Infect"},{"key":"2021122708482622100_b92","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","article-title":"Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"146","author":"Ravelli","year":"2005","journal-title":"J Pediatr"},{"key":"2021122708482622100_b93","first-page":"697","article-title":"A single amino acid change A91V in perforin: a novel, frequent predisposing factor to childhood acute lymphoblastic leukemia?","volume":"90","author":"Santoro","year":"2005","journal-title":"Haematologica"},{"key":"2021122708482622100_b94","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.192.5.755","article-title":"Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma","volume":"192","author":"Smyth","year":"2000","journal-title":"J Exp Med"},{"key":"2021122708482622100_b95","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.1542\/peds.2005-1789","article-title":"Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients","volume":"117","author":"Ouachee-Chardin","year":"2006","journal-title":"Pediatrics"},{"key":"2021122708482622100_b96","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajh.20462","article-title":"Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis","volume":"81","author":"Henzan","year":"2006","journal-title":"Am J Hematol"},{"key":"2021122708482622100_b97","first-page":"2120","article-title":"Etanercept in the treatment of macrophage activation syndrome","volume":"28","author":"Prahalad","year":"2001","journal-title":"J Rheumatol"},{"key":"2021122708482622100_b98","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mpo.1294","article-title":"Alpha-CD25 antibody treatment in a child with hemophagocytic lymphohistiocytosis","volume":"38","author":"Tomaske","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"2021122708482622100_b99","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/adc.84.4.373a","article-title":"Fludarabine in the treatment of an active phase of a familial haemophagocytic lymphohistiocytosis","volume":"84","author":"Schneider","year":"2001","journal-title":"Arch Dis Child"},{"key":"2021122708482622100_b100","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/emmm.200900009","article-title":"Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice","volume":"1","author":"Pachlopnik Schmid","year":"2009","journal-title":"EMBO Mol Med"},{"key":"2021122708482622100_b101","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0022-3476(86)81002-2","article-title":"Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis","volume":"108","author":"Fischer","year":"1986","journal-title":"J Pediatr"},{"key":"2021122708482622100_b102","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter","year":"2002","journal-title":"Blood"},{"key":"2021122708482622100_b103","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2005.05501.x","article-title":"Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis","volume":"129","author":"Horne","year":"2005","journal-title":"Br J Haematol"},{"key":"2021122708482622100_b104","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood-2005-05-1819","article-title":"Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis","volume":"107","author":"Cooper","year":"2006","journal-title":"Blood"},{"issue":"2","key":"2021122708482622100_b105","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1038\/bmt.2008.283","article-title":"The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis","volume":"42","author":"Cooper","year":"2008","journal-title":"Bone Marrow Transplant"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2010.04302.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/163\/3\/271\/41909663\/j.1365-2249.2010.04302.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/163\/3\/271\/41909663\/j.1365-2249.2010.04302.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T11:25:41Z","timestamp":1641036341000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/163\/3\/271\/6428977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,8]]},"references-count":105,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,2,8]]},"published-print":{"date-parts":[[2011,2,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04302.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,3]]},"published":{"date-parts":[[2011,2,8]]}}}